E-LIB Suche - Ergebnisse für: Werth, Victoria P

1

Expert consensus achieved on a working core outcome set for..:

Zhang, Arianna J ; Perez-Chada, Lourdes M ; Werth, Victoria P.
Lupus Science & Medicine. 11 (2024) 1 - p. e001165 , 2024

Link: https://doi.org/10.1136/..

2

Clinical characteristics and symptom progression of dermato..:

Pandya, Rachita ; Kleitsch, Julianne ; Lim, Darosa.
Journal of the American Academy of Dermatology. 91 (2024) 1 - p. 31-36 , 2024

Link: https://doi.org/10.1016/..

3

Study Design of a Phase 2/3 Randomized Controlled Trial of ..:

Murrell, Dédée F. ; Joly, Pascal ; Werth, Victoria P....
Advances in Therapy. 41 (2024) 7 - p. 2991-3002 , 2024

Link: https://doi.org/10.1007/..

4

Evaluation of RNase therapy in systemic lupus erythematosus..:

Burge, Daniel J ; Werth, Victoria P ; Boackle, Susan A.
Lupus Science & Medicine. 11 (2024) 1 - p. e001113 , 2024

Link: https://doi.org/10.1136/..

5

Plain Language Summary of the PAISLEY study: deucravacitini..:

Morand, Eric F. ; Pike, Marilyn ; Merrill, J...
Expert Opinion on Investigational Drugs. 33 (2024) 5 - p. 431-440 , 2024

Link: https://doi.org/10.1080/..

6

An update on clinical trials for cutaneous lupus erythemato..:

Xie, Lillian ; Lopes Almeida Gomes, Lais ; Stone, Caroline J...
The Journal of Dermatology. 51 (2024) 7 - p. 885-894 , 2024

Link: https://doi.org/10.1111/..

7

Updates in Dermatomyositis: Newer Treatment Options and Out..:

Kim, Hee Joo ; Werth, Victoria P.
Annals of Dermatology. 36 (2024) - p. , 2024

Link: https://doi.org/10.5021/..

8

Overview of Clinical Trials With Efgartigimod in Autoimmune..:

Vassileva, Snejina ; Murrell, Dedee F. ; Culton, Donna A....
SKIN The Journal of Cutaneous Medicine. 8 (2024) 1 - p. s345 , 2024

Link: https://doi.org/10.25251..

9

Author Correction: International Guideline for Idiopathic I..:

Oldroyd, Alexander G. S. ; Callen, Jeffrey P. ; Chinoy, Hector...
Nature Reviews Rheumatology. 20 (2024) 5 - p. 315-315 , 2024

Link: https://doi.org/10.1038/..

10

Change in disease activity needed for meaningful change in ..:

Kleitsch, Julianne ; Pandya, Rachita ; Chakka, Srita...
Journal of the American Academy of Dermatology. 90 (2024) 2 - p. 406-408 , 2024

Link: https://doi.org/10.1016/..

11

Correction to: Study Design of a Phase 2/3 Randomized Contr..:

Murrell, Dédée F. ; Joly, Pascal ; Werth, Victoria P....
Advances in Therapy. 41 (2024) 7 - p. 3014-3015 , 2024

Link: https://doi.org/10.1007/..

12

Editorial: Cutaneous lupus erythematosus landscape: pathoph..:

Merola, Joseph F. ; Nyberg, Filippa ; Franchimont, Nathalie..
Frontiers in Medicine. 11 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

13

Extracellular Vesicles in the Pathogenesis, Clinical Charac..:

Ricco, Cristina ; Eldaboush, Ahmed ; Liu, Ming-Lin.
International Journal of Molecular Sciences. 25 (2024) 4 - p. 1967 , 2024

Link: https://doi.org/10.3390/..

14

Multiplexed mass cytometry of cutaneous lupus erythematosus..:

Ogawa-Momohara, Mariko ; Vazquez, Thomas ; Chin, Felix...
Journal of Investigative Dermatology. , 2024

Link: https://doi.org/10.1016/..

15

Efficacy and Safety of Rilzabrutinib in Pemphigus: PEGASUS ..:

Murrell, Dedee F. ; Caux, Frédéric ; Patsatsi, Aikaterini...
Journal of Investigative Dermatology. 144 (2024) 8 - p. 1762-1771.e6 , 2024

Link: https://doi.org/10.1016/..